Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Kovsies defend tennis title in Sun City
2017-04-01

 Description: 'Kovsie Tennis Sun City Tags: Kovsie Tennis Sun City

The first and second tennis teams of the University of the
Free State 
were first and fifth respectively among the 14
teams competing 
in the Egalite Invitational challenge.
Photo: Arne Nel

Although a tournament victory was not the Kovsie tennis team’s main goal, they still managed to outplay the best in the country.

The first team of the University of the Free State (UFS), who have been the champions of the combined USSA format for the past six years, successfully defended its title to end the Egalite Invitational challenge in Sun City unbeaten.

Second team also performing well

On 26 March 2017, the Kovsie first team defeated Puk’s first team 35-20 (games) in the final. Their second team also performed well and won against Tuks’ second team 31-21 to end fifth among the 14 teams. The matches in the tournament, which took place from 24 to 26 March 2017, were played in World Team Tennis format.

In the group stages, the Kovsie first team beat Puk’s second (35-12), Puk’s fourth (35-8), Tuks’ second (35-12), Maties’ first (31-19), Puk’s sixth (35-5), and Tuks’ third (32-16) teams. The team consists of Arne Nel, Christo Koekemoer, Emke Kruger, Lienke de Kock, Ansunica Brits, and Reze Opperman.

Preparation for USSA

Apart from USSA, the Sun City tournament is the other major tournament in which the UFS annually competes. “Of course you want to win, but unlike at USSA, this was not our main focus in Sun City,” says Janine de Kock, the Kovsie team manager. “We wanted to try new combinations and provide exposure to new players.”

A total of five of the 12 players in the two teams were newcomers. They are Lienke de Kock (first team), Handré Hoffman, JC Conradie, Brieta Pienaar, and Daniel de Villiers (all second team). According to Janine de Kock, it was especially important to test new doubles combinations before USSA.

“We always knew the first team is a good team with a chance, but we are very impressed with the second team’s fifth place.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept